Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus
出版年份 2018 全文链接
标题
Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus
作者
关键词
-
出版物
JOURNAL OF VIROLOGY
Volume 92, Issue 20, Pages -
出版商
American Society for Microbiology
发表日期
2018-08-06
DOI
10.1128/jvi.01088-18
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Exceptional potency and structural basis of a T1249-derived lipopeptide fusion inhibitor against HIV-1, HIV-2, and simian immunodeficiency virus
- (2018) Yuanmei Zhu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fusion Inhibitory Lipopeptides Engineered for Prophylaxis of Nipah Virus in Primates
- (2018) Cyrille Mathieu et al. JOURNAL OF INFECTIOUS DISEASES
- Design of Novel HIV-1/2 Fusion Inhibitors with Efficient Therapeutic Efficacy in Rhesus Monkey Models
- (2018) Huihui Chong et al. JOURNAL OF VIROLOGY
- Enfuvirtide (T20)-Based Lipopeptide Is a Potent HIV-1 Cell Fusion Inhibitor: Implications for Viral Entry and Inhibition
- (2017) Xiaohui Ding et al. JOURNAL OF VIROLOGY
- A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro , Ex Vivo , and In Vivo Antiviral Activity
- (2017) Huihui Chong et al. JOURNAL OF VIROLOGY
- Development of potent and long-acting HIV-1 fusion inhibitors
- (2016) Huihui Chong et al. AIDS
- A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus
- (2016) Shengwen Xiong et al. JOURNAL OF VIROLOGY
- Design of a highly potent HIV-1 fusion inhibitor targeting the gp41 pocket
- (2015) Huihui Chong et al. AIDS
- The N-Terminal T–T Motif of a Third-Generation HIV-1 Fusion Inhibitor Is Not Required for Binding Affinity and Antiviral Activity
- (2015) Huihui Chong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanism of HIV-1 Resistance to Short-Peptide Fusion Inhibitors Targeting the Gp41 Pocket
- (2015) Yang Su et al. JOURNAL OF VIROLOGY
- The M-T hook structure increases the potency of HIV-1 fusion inhibitor sifuvirtide and overcomes drug resistance
- (2014) Huihui Chong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Two M-T hook residues greatly improve the antiviral activity and resistance profile of the HIV-1 fusion inhibitor SC29EK
- (2014) Huihui Chong et al. Retrovirology
- An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity
- (2013) Pedro Borrego et al. AIDS
- Synthesized Peptide Inhibitors of HIV-1 gp41-dependent Membrane Fusion
- (2013) Yuxian He CURRENT PHARMACEUTICAL DESIGN
- Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1
- (2012) Avraham Ashkenazi et al. FASEB JOURNAL
- Short-peptide fusion inhibitors with high potency against wild-type and enfuvirtide-resistant HIV-1
- (2012) Huihui Chong et al. FASEB JOURNAL
- Discovery of Critical Residues for Viral Entry and Inhibition through Structural Insight of HIV-1 Fusion Inhibitor CP621–652
- (2012) Huihui Chong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Broad Antiviral Activity and Crystal Structure of HIV-1 Fusion Inhibitor Sifuvirtide
- (2012) Xue Yao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Basis of Potent and Broad HIV-1 Fusion Inhibitor CP32M
- (2012) Xue Yao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The M-T Hook Structure Is Critical for Design of HIV-1 Fusion Inhibitors
- (2012) Huihui Chong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of HIV-1 by Fusion Inhibitors
- (2010) Dirk Eggink et al. CURRENT PHARMACEUTICAL DESIGN
- Peptide-Based Inhibitors of the HIV Envelope Protein and Other Class I Viral Fusion Proteins
- (2010) Imke Steffen et al. CURRENT PHARMACEUTICAL DESIGN
- Viral Entry Inhibitors Targeted to the Membrane Site of Action
- (2010) M. Porotto et al. JOURNAL OF VIROLOGY
- Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency
- (2009) P. Ingallinella et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Membrane-Anchored HIV-1 N-Heptad Repeat Peptides Are Highly Potent Cell Fusion Inhibitors via an Altered Mode of Action
- (2009) Yael Wexler-Cohen et al. PLoS Pathogens
- Design and Evaluation of Sifuvirtide, a Novel HIV-1 Fusion Inhibitor
- (2008) Yuxian He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of a Critical Motif for the Human Immunodeficiency Virus Type 1 (HIV-1) gp41 Core Structure: Implications for Designing Novel Anti-HIV Fusion Inhibitors
- (2008) Y. He et al. JOURNAL OF VIROLOGY
- Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains
- (2008) Y. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started